MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias

C. Lin, L. Peppel, R. Lai, C. Rummey, P. Opal, J. Schmahmann, C. Gomez, H. Paulson, T. Zesiewicz, S. Perlman, G. Wilmot, S. Ying, C. Onyike, K. Bushara, M. Geschwind, K. Figueroa, S. Pulst, S. Subramony, A. Duquette, T. Ashizawa, A. Hamedani, M. Davis, S. Srinivasan, M. Burns, L. Moore, V. Shakkottai, L. Rosenthal, S. Kuo (Houston, USA)

Meeting: 2024 International Congress

Abstract Number: 1286

Keywords: Ataxia: Clinical features, Cerebellum, Spinocerebellar ataxia

Category: Ataxia

Objective: We aimed to investigate if individuals with spinocerebellar ataxias (SCAs) experience increased suicidal ideation and to identify associated factors.

Background: Suicidality has been extensively studied in various neurodegenerative disorders, including Huntington’s disease, Parkinson’s disease, dystonia, and dementia with Lewy bodies. However, it has not been thoroughly explored in SCAs.

Method: We examined 781 patients with genetically-confirmed SCAs from the Clinical Research Consortium for the Study of Cerebellar Ataxia, the largest SCA cohort in North America. We assessed the percentage of SCA1, 2, 3, 6, and 7 patients who reported suicidal ideation and compared it with the prevalence of suicidal ideation in the general U.S. population, using data from The National Survey on Drug Use and Health survey from 2015 to 2019. The Clopper-Pearson confidence limits for the prevalence of suicidal ideation of SCAs was also calculated to determine its confidence when compared to the general population. Additionally, we analyzed the clinical characteristics that may contribute to suicidal ideation in SCAs, including age, disease duration, sex, ataxia severity, and depression.

Results: Suicidal ideation was present in 11.8% of individuals with SCAs (Clopper-Pearson CI: 9.60-14.15%, p < 0.001), which was significantly higher than the 4.3% prevalence in the U.S. population (odds ratio of 2.97, p < 0.001). Patients with SCAs who reported suicidal ideation had longer disease duration (11.48 ± 6.88 vs. 9.93 ± 8.63 years, p = 0.015), more severe ataxia (scale for the assessment and rating of ataxia: 17.40 ± 8.76 vs. 12.94 ± 7.83, p < 0.001), and more severe depression (10.38 ± 5.72 vs. 4.95 ± 4.80, p < 0.001) compared to those without suicidal ideation.

Conclusion: Suicidal ideation is more prevalent among individuals with SCAs compared to the general population. Our study underscores the importance of screening for suicidal risk in patients with SCAs.

References: N/A

To cite this abstract in AMA style:

C. Lin, L. Peppel, R. Lai, C. Rummey, P. Opal, J. Schmahmann, C. Gomez, H. Paulson, T. Zesiewicz, S. Perlman, G. Wilmot, S. Ying, C. Onyike, K. Bushara, M. Geschwind, K. Figueroa, S. Pulst, S. Subramony, A. Duquette, T. Ashizawa, A. Hamedani, M. Davis, S. Srinivasan, M. Burns, L. Moore, V. Shakkottai, L. Rosenthal, S. Kuo. Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/increased-risk-of-suicidal-ideation-in-patients-with-spinocerebellar-ataxias/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/increased-risk-of-suicidal-ideation-in-patients-with-spinocerebellar-ataxias/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley